Concizumab

(Synonyms: NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody)
1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 98.12%
  • No. CAS: 1312299-39-0
  • Peso molecular:146.28 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Concizumab

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00